Vol. 13 Nbr. 1, March 2008
- Controversies in current treatment guidelines.
- Nucleoside analogues in 2008.
- The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
- Key clinical trials of non-nucleoside reverse transcriptase inhibitors in the treatment of chronic HIV-1 infection in adults.
- HLA-B*5701 screening for hypersensitivity to abacavir.
- Metabolic effects of a growth hormone-releasing factor in patients with HIV.